Preventice out of Minneapolis, Minnesota, having received FDA approval last year for remote monitoring of individuals with non-lethal cardiac arrhythmias, is launching its BodyGuardian Remote Patient Monitoring System. The core technology behind the BodyGuardian was developed at the Mayo Clinic and involves processing of live data such as ECG, heart rate, heart rate variability, respiration rate, and the person’s activity level gathered from a sensor attached to the patient’s chest.
Cardiologists and other clinicians can keep a close eye on their patients throughout the day while special algorithms analyze a month’s worth of data and provide reports on patient status that would otherwise require much manual labor.
Here are Mayo Clinic cardiologists discussing the benefits of remote monitoring:
Flashback: Preventice BodyGuardian Ambulatory Arrhythmia Monitoring System
Product page: BodyGuardian Remote Monitoring System…
Press release: Preventice announces commercial availability of BodyGuardian Remote Patient Monitoring System(TM)